Micaela Weaver, DO, FACS: No relevant financial relationships with any proprietary interests.
Learning Objectives:
Upon completion, the participant will be able to describe the rationale for genetic testing of breast cancer patients and/or patients who may have increased risk of having a genetic mutation.
Upon completion, the participant will be able to identify patients eligible for testing and map the testing process.
Upon completion, the participant will be able to summarize the recommendations for management of patients with a breast-related genetic mutations.
Upon completion, the participant will be able to explain the pitfalls of direct-to-consumer genetic testing.
